Cerebral Blood Flow, Metabolism & Autoregulation

ABPN Neurocritical Care Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU

Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU

2 Chapter 2: Cerebral Physiology & Intracranial Dynamics

Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes

3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management

Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions

4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management

Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy

5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management

Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury

6 Chapter 6: Neuropharmacology, Analgesia & Sedation

ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU

7 Bleeding, Thrombosis & Hematologic Emergencies

Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity

8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine

Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention

9 Systemic Trauma & Environmental Injury

Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging

10 Cardiac Emergencies & Mechanical Support

IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies

11 Kidney Injury, Acid–Base & Renal Replacement

Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement

12 Systemic Infection & Endocrine Emergencies

Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies

13 Gastrointestinal & Hepatic Emergencies

Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects

14 Chapter 9: Neuroimaging in the Neuro-ICU

Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness

15 Chapter 10: Electrophysiology & Neuromonitoring

Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler

16 Angiography, Electrodiagnosis & CSF Analysis

Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage

17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria

Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria

18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies

Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction

19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage

Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH

20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia

Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations

21 Venous, Spinal & Traumatic Vascular Disease

Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury

22 Chapter 15: Traumatic Brain & Spinal Cord Injury

Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes

23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies

Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure

24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis

Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies

25 Neuroinflammation & Neurooncology

Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies

26 Pregnancy, Transplantation & Pediatric Care

Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care

27 Chapter 18: Neurosurgical & Perioperative Emergencies

Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU

Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor

Cerebral Blood Flow, Metabolism & Autoregulation

Key Takeaways Explain This Topic AI

Normal resting cerebral blood flow (CBF) averages approximately 50 mL / 100 g / min 50\text{ mL}/100\text{g}/\text{min} 50 mL /100 g / min , with cortical gray matter receiving 80 mL / 100 g / min 80\text{ mL}/100\text{g}/\text{min} 80 mL /100 g / min and subcortical white matter receiving 20 mL / 100 g / min 20\text{ mL}/100\text{g}/\text{min} 20 mL /100 g / min .

Cerebral metabolic rate of oxygen ( CMRO 2 \text{CMRO}_2 CMRO 2 ​ ) is 3.0 – 3.5 mL / 100 g / min 3.0\text{--}3.5\text{ mL}/100\text{g}/\text{min} 3.0 – 3.5 mL /100 g / min ; ischemic thresholds progress from oligemia ( 35 – 50 mL / 100 g / min 35\text{--}50\text{ mL}/100\text{g}/\text{min} 35 – 50 mL /100 g / min ) to penumbral electrical failure ( 10 – 20 mL / 100 g / min 10\text{--}20\text{ mL}/100\text{g}/\text{min} 10 – 20 mL /100 g / min ) to membrane pump failure and irreversible infarction ( < 10 – 12 mL / 100 g / min <10\text{--}12\text{ mL}/100\text{g}/\text{min} < 10 – 12 mL /100 g / min ).

The Lassen autoregulatory plateau maintains constant CBF across mean arterial pressures of 50 – 150 mmHg 50\text{--}150\text{ mmHg} 50 – 150 mmHg , but this curve shifts rightward in chronic hypertension and is abolished in acute brain injury, resulting in pressure-passive perfusion.

PaCO 2 \text{PaCO}_2 PaCO 2 ​ is the most potent chemical regulator of CBF, altering flow by 1 – 2 mL / 100 g / min 1\text{--}2\text{ mL}/100\text{g}/\text{min} 1 – 2 mL /100 g / min per 1 mmHg 1\text{ mmHg} 1 mmHg change between 20 – 60 mmHg 20\text{--}60\text{ mmHg} 20 – 60 mmHg ; severe hyperventilation risks secondary cerebral ischemia.

The pressure reactivity index (PRx) quantifies autoregulatory integrity as the correlation between arterial pressure and ICP; values > 0.2 – 0.3 >0.2\text{--}0.3 > 0.2 – 0.3 signify impaired autoregulation, and continuous PRx curves identify optimal cerebral perfusion pressure ( CPP opt \text{CPP}_{\text{opt}} CPP opt ​ ).

Last updated: October 2026

2.1 Cerebral Blood Flow, Metabolism & Autoregulation

The adult human brain represents roughly 2% of total body mass (~1400 g), yet it receives 15% to 20% of resting cardiac output and consumes 20% of basal oxygen and 25% of glucose. Because the central nervous system lacks significant energy reserves, continuous regulation of cerebral blood flow (CBF) is essential to match metabolic demand and prevent secondary ischemic injury.

Normal Cerebral Blood Flow and Flow-Metabolism Coupling

Global resting cerebral blood flow in healthy adults averages 50 mL / 100 g / min 50\text{ mL}/100\text{g}/\text{min} 50 mL /100 g / min (~ 700 – 750 mL / min 700\text{--}750\text{ mL}/\text{min} 700 – 750 mL / min ). Perfusion displays marked regional variation:

Cortical Gray Matter: Consumes 80 mL / 100 g / min 80\text{ mL}/100\text{g}/\text{min} 80 mL /100 g / min , supporting the high metabolic demands of neuronal somas, dendrites, and synaptic transmission.

Subcortical White Matter: Consumes 20 mL / 100 g / min 20\text{ mL}/100\text{g}/\text{min} 20 mL /100 g / min , supplying lower metabolic requirements of myelinated axonal pathways.

Under resting conditions, the cerebral metabolic rate of oxygen ( CMRO 2 \text{CMRO}_2 CMRO 2 ​ ) averages 3.0 to 3.5 mL / 100 g / min 3.0\text{ to }3.5\text{ mL}/100\text{g}/\text{min} 3.0 to 3.5 mL /100 g / min ( 130 – 150 μ mol / 100 g / min 130\text{--}150\text{ }\mu\text{mol}/100\text{g}/\text{min} 130 – 150 μ mol /100 g / min ), while the cerebral metabolic rate of glucose ( CMR glc \text{CMR}_{\text{glc}} CMR glc ​ ) averages 4.5 to 5.5 mg / 100 g / min 4.5\text{ to }5.5\text{ mg}/100\text{g}/\text{min} 4.5 to 5.5 mg /100 g / min ( 25 – 30 μ mol / 100 g / min 25\text{--}30\text{ }\mu\text{mol}/100\text{g}/\text{min} 25 – 30 μ mol /100 g / min ). Under aerobic conditions, oxidative phosphorylation of glucose supplies virtually all cellular ATP.

Neurovascular Coupling

Flow-metabolism coupling occurs on a millisecond timescale through the tripartite synapse. Astrocytic end-feet envelop microvessels. Synaptic glutamate activates astrocytic mGluR and NMDA receptors, elevating intracellular Ca 2 + \text{Ca}^{2+} Ca 2 + . This mobilizes epoxyeicosatrienoic acids (EETs) and prostaglandin E 2 \text{E}_2 E 2 ​ , alongside neuronal nitric oxide (NO) and astrocytic potassium ( K + \text{K}^+ K + ) efflux through BK \text{BK} BK channels. These mediators relax arteriolar smooth muscle, dynamically tuning microvascular caliber to local synaptic activity.

Note

Flow-metabolism coupling increases regional CBF in excess of oxygen consumption during neural activation, producing local capillary hyperoxygenation that forms the physical basis for BOLD functional MRI.

Ischemic Flow Thresholds and the Penumbra

Progressive reductions in CBF produce sequential neurochemical and functional failures across distinct thresholds:

Perfusion State CBF ( mL / 100 g / min \text{mL}/100\text{g}/\text{min} mL /100 g / min ) Cellular Status Clinical & Electrophysiologic Impact

Normal Perfusion > 50 >50 > 50 Baseline CMRO2; normal ATP pools Fully preserved neurologic function

Relative Oligemia 35 – 50 35\text{--}50 35 – 50 Compensatory OEF rise (up to 70-80%) Asymptomatic; normal EEG; intact viability

Electrical Failure (Penumbra) 10 – 20 10\text{--}20 10 – 20 Synaptic silence; declining ATP; acidosis Isoelectric EEG; loss of evoked potentials; reversible

Membrane Failure (Infarction) < 10 – 12 <10\text{--}12 < 10 – 12 Total ATP depletion; Na + / K + \text{Na}^+/\text{K}^+ Na + / K + -pump collapse Anoxic depolarization, cytotoxic edema, necrosis

Between 10 and 20 mL / 100 g / min 10\text{ and }20\text{ mL}/100\text{g}/\text{min} 10 and 20 mL /100 g / min , neurons arrest electrical activity to conserve dwindling ATP pools for structural survival. This represents the ischemic penumbra —functionally silent tissue that remains salvageable if reperfusion occurs before membrane pump failure supervenes.

Mechanisms of Cerebral Autoregulation and the Lassen Curve

Cerebral autoregulation maintains stable CBF despite changes in cerebral perfusion pressure ( CPP = MAP − ICP \text{CPP} = \text{MAP} - \text{ICP} CPP = MAP − ICP ) via three coordinated mechanisms:

Myogenic Response (Bayliss Effect): Arteriolar smooth muscle reacts directly to transmural pressure. Increased wall tension opens stretch-sensitive cation channels, causing membrane depolarization, calcium influx via L-type channels, and vasoconstriction. Reduced pressure causes vessel relaxation and dilation.

Metabolic Control: Hypoperfusion causes local accumulation of vasodilators (adenosine, H + \text{H}^+ H + , lactate, K + \text{K}^+ K + , NO), triggering arteriolar dilation.

Neurogenic Regulation: Extrinsic sympathetic innervation from the superior cervical ganglion modulates large pial vessels, shifting the upper autoregulatory limit upward during acute hypertensive surges.

The Lassen Curve

Under physiologic conditions, the classical Lassen curve maintains steady CBF across a mean arterial pressure (MAP) or CPP plateau of 50 to 150 mmHg 50\text{ to }150\text{ mmHg} 50 to 150 mmHg :

Below 50 mmHg 50\text{ mmHg} 50 mmHg (Lower Limit): Arterioles are maximally dilated; flow becomes pressure-passive, precipitating penumbral ischemia.

Above 150 mmHg 150\text{ mmHg} 150 mmHg (Upper Limit): Autoregulatory breakthrough occurs. Forced vasodilation disrupts the blood-brain barrier (BBB), causing vasogenic edema and petechial hemorrhage (as in PRES and hypertensive encephalopathy).

Pathologic States

Chronic Hypertension: Medial arteriolar hypertrophy shifts the Lassen curve to the right (lower limit rising to MAP 80 – 90 mmHg 80\text{--}90\text{ mmHg} 80 – 90 mmHg ). Rapidly lowering blood pressure to conventional normal levels induces border-zone watershed infarction.

Acute Brain Injury: Severe TBI, aneurysmal SAH, and stroke frequently abolish autoregulation. Perfusion becomes entirely pressure-passive : hypotension induces immediate ischemia, whereas hypertension escalates ICP and edema.

Warning

In patients with chronic hypertension presenting with acute stroke, never rapidly reduce blood pressure to standard normotensive targets. Their right-shifted lower autoregulation limit risks severe watershed ischemia.

Chemical Regulation: Arterial PaCO 2 \text{PaCO}_2 PaCO 2 ​ and PaO 2 \text{PaO}_2 PaO 2 ​

Arterial blood gases strongly influence microvascular tone:

PaCO 2 \text{PaCO}_2 PaCO 2 ​ Responsiveness: Between 20 and 60 mmHg 20\text{ and }60\text{ mmHg} 20 and 60 mmHg , CBF changes by 1 to 2 mL / 100 g / min 1\text{ to }2\text{ mL}/100\text{g}/\text{min} 1 to 2 mL /100 g / min per 1 mmHg 1\text{ mmHg} 1 mmHg change in PaCO 2 \text{PaCO}_2 PaCO 2 ​ (~2% to 4% per mmHg). Carbon dioxide diffuses across the BBB to alter perivascular pH \text{pH} pH ; alkalosis induces vasoconstriction, while acidosis triggers vasodilation. Prolonged hyperventilation ( PaCO 2 < 30 mmHg \text{PaCO}_2 < 30\text{ mmHg} PaCO 2 ​ < 30 mmHg ) induces severe vasoconstriction, causing secondary tissue ischemia.

PaO 2 \text{PaO}_2 PaO 2 ​ Responsiveness: Perfusion remains stable across PaO 2 \text{PaO}_2 PaO 2 ​ levels of 60 to 300 mmHg 60\text{ to }300\text{ mmHg} 60 to 300 mmHg . However, when PaO 2 \text{PaO}_2 PaO 2 ​ falls below 50 mmHg 50\text{ mmHg} 50 mmHg , CBF increases exponentially to preserve cerebral oxygen delivery.

Important

Prophylactic hyperventilation is strictly contraindicated in acute brain injury. Hyperventilation is restricted to brief, emergency stabilization during acute herniation crises while definitive therapies are deployed.

Autoregulation Indices: PRx and Optimal CPP

Bedside neuromonitoring quantifies dynamic autoregulation continuously:

Pressure Reactivity Index (PRx): Computed as the moving linear Pearson correlation coefficient between slow spontaneous oscillations (periods 20 s 20\text{ s} 20 s to 3 min 3\text{ min} 3 min ) of arterial blood pressure (ABP) and ICP.

Negative or Zero PRx ( < 0 <0 < 0 to 0 0 0 ): Intact autoregulation. Surges in ABP cause active arteriolar vasoconstriction, maintaining or reducing ICP.

Positive PRx ( > 0.2 – 0.3 >0.2\text{--}0.3 > 0.2 – 0.3 ): Impaired or lost autoregulation. Arterioles act as passive conduits; ABP surges transmit directly into cerebral capillary beds, driving proportional ICP spikes.

Optimal CPP ( CPP opt \text{CPP}_{\text{opt}} CPP opt ​ ): Plotting PRx against CPP generates a U-shaped curve. The nadir represents CPP opt \text{CPP}_{\text{opt}} CPP opt ​ —the pressure where autoregulatory reactivity is maximal (typically 60 – 70 mmHg 60\text{--}70\text{ mmHg} 60 – 70 mmHg ). CPPopt is an individualized monitoring concept under investigation; targeting it has not been established as a universal outcome-improving standard.